Personalised Bioelectronics for Epithelial Repair
ProBER aims to develop personalized bioelectronic wound dressings using conformal DC electrodes to enhance healing speed and efficiency in chronic wounds, preparing for clinical studies.
Projectdetails
Introduction
Care of chronic wounds constitutes an enormous socioeconomic burden to the European Healthcare system, calling for new strategies to support healing for wounds at risk. As a restored epithelium will outperform any artificial scaffold in protecting the underlying tissue, fast re-epithelialization is the primary goal.
Current Findings
In culture models of wound healing, we have shown that direct current stimulation (DCs) makes epithelial ruptures close up to three times faster, and that the key to success is dosage. This aspect is overlooked in previous clinical studies. Typically, DCs thresholds established in cultures are lost in translation because of the lack of technologies able to support DCs on the skin.
Project Overview
In ProBER, we will change this. We will exploit technologies for making conformal, metal-free, biocompatible DCs electrodes for skin developed in the ERC StG SPEEDER. By focusing on personalization of the bioelectronic wound dressing, we will ensure that the same efficient parameter space established in culture models can be precisely replicated on actual wounds.
Goals and Methodology
Our goal is a fabrication pipeline with wound dressings tailored to the wound. We will:
- Collect information on wound size and shape using LIDAR 3D scanning.
- Feed this information, as well as impedance measurements, to an automated personalization algorithm.
Personalization extends beyond fabrication as the ProBER wound dressing will include integrated impedance sensors to ensure that DCs is adapted to the healing progress.
Future Steps
In ProBER, we will prepare our promising concept for subsequent clinical studies, which requires a functional concept for fabrication and proof-of-concept demonstration. We will co-develop our wound dressing together with stakeholders in healthcare and work to:
- Protect IP
- Recruit strategic partners
- Form alliances for clinical translation
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-6-2023 |
Einddatum | 30-11-2024 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- CHALMERS TEKNISKA HOGSKOLA ABpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Nanoengineered photoactivated drug-free antimicrobial precision treatment for chronic skin woundsThis project aims to validate a drug-free PHOTOCURE wound patch that uses photocatalytic activity to effectively eradicate antibiotic-resistant biofilms in chronic skin infections like diabetic foot ulcers. | ERC Proof of... | € 150.000 | 2024 | Details |
Redesigning aortic endograft: enabling in-situ personalized aneurysm healingEPEIUS aims to revolutionize aortic aneurysm treatment by developing a bioengineered, 3D-printed, drug-loaded endograft for early personalized healing through innovative in-vitro models. | ERC Consolid... | € 1.991.225 | 2024 | Details |
Development of a non-invasive medical device to measure the skin biomechanical properties: assessment of the commercial feasibilityAssesSkin aims to develop a non-invasive medical device for assessing skin biomechanical properties, enhancing personalized treatment in dermatology and cosmetics while addressing regulatory pathways. | ERC Proof of... | € 150.000 | 2024 | Details |
A Digitally-Enabled Electroconductive Patient-Specific Stimulation Implant for Spinal Cord InjuryThis project aims to develop a patient-specific 3D-printed neuromodulation implant to enhance neuron regrowth and restore function in spinal cord injury patients through targeted electrical stimulation. | ERC Proof of... | € 150.000 | 2025 | Details |
Regenerative Engineering of Living Autologous InterfacesRELAI aims to develop innovative bioelectronic technologies for neural interfacing to enhance information transduction and treat chronic conditions through advanced biohybrid interfaces. | ERC Proof of... | € 150.000 | 2025 | Details |
Nanoengineered photoactivated drug-free antimicrobial precision treatment for chronic skin wounds
This project aims to validate a drug-free PHOTOCURE wound patch that uses photocatalytic activity to effectively eradicate antibiotic-resistant biofilms in chronic skin infections like diabetic foot ulcers.
Redesigning aortic endograft: enabling in-situ personalized aneurysm healing
EPEIUS aims to revolutionize aortic aneurysm treatment by developing a bioengineered, 3D-printed, drug-loaded endograft for early personalized healing through innovative in-vitro models.
Development of a non-invasive medical device to measure the skin biomechanical properties: assessment of the commercial feasibility
AssesSkin aims to develop a non-invasive medical device for assessing skin biomechanical properties, enhancing personalized treatment in dermatology and cosmetics while addressing regulatory pathways.
A Digitally-Enabled Electroconductive Patient-Specific Stimulation Implant for Spinal Cord Injury
This project aims to develop a patient-specific 3D-printed neuromodulation implant to enhance neuron regrowth and restore function in spinal cord injury patients through targeted electrical stimulation.
Regenerative Engineering of Living Autologous Interfaces
RELAI aims to develop innovative bioelectronic technologies for neural interfacing to enhance information transduction and treat chronic conditions through advanced biohybrid interfaces.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic NeomaterialsWOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life. | EIC Pathfinder | € 2.934.318 | 2023 | Details |
iCap Fotobiomodulatie apparaatDit project valideert een innovatief biofotomodulatie apparaat voor de genezing van complexe wonden bij diabetes type 2 patiënten. | 1.1 - Het ve... | € 32.000 | 2024 | Details |
Haalbaarheidsonderzoek slimme pleister voor zweet analyse ten behoeve van wondzorgHet project onderzoekt de haalbaarheid van een betaalbare slimme pleister die realtime lactaat meet om decubitus te voorkomen. | Mkb-innovati... | € 20.000 | 2021 | Details |
Eggshell membrane based wound dressing – a solution for chronic wound cureEGGXPERT ontwikkelt een innovatieve wondpleister van eierschaalmembraan voor effectieve genezing van huidzweren met minimale littekens. | Mkb-innovati... | € 20.000 | 2022 | Details |
NXGHet NXG-project ontwikkelt een gebruiksvriendelijk, contactloos systeem voor efficiënte wondmonitoring, waardoor patiënten meer regie krijgen en zorgkosten verlaagd worden. | Mkb-innovati... | € 116.419 | 2017 | Details |
A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterials
WOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life.
iCap Fotobiomodulatie apparaat
Dit project valideert een innovatief biofotomodulatie apparaat voor de genezing van complexe wonden bij diabetes type 2 patiënten.
Haalbaarheidsonderzoek slimme pleister voor zweet analyse ten behoeve van wondzorg
Het project onderzoekt de haalbaarheid van een betaalbare slimme pleister die realtime lactaat meet om decubitus te voorkomen.
Eggshell membrane based wound dressing – a solution for chronic wound cure
EGGXPERT ontwikkelt een innovatieve wondpleister van eierschaalmembraan voor effectieve genezing van huidzweren met minimale littekens.
NXG
Het NXG-project ontwikkelt een gebruiksvriendelijk, contactloos systeem voor efficiënte wondmonitoring, waardoor patiënten meer regie krijgen en zorgkosten verlaagd worden.